Background: The burden perceived by the patient of repeated imaging required for neoadjuvant chemotherapy (NAC) monitoring warrants attention due to the increased use of NAC and imaging.
Purpose: To evaluate and compare the experienced burden associated with repeated contrast-enhanced mammography (CEM) and magnetic resonance imaging (MRI) during NAC for breast cancer from the patient perspective.
Material And Methods: Approval from the ethics committee and written informed consent were obtained.
: Primary breast angiosarcoma should be in the differential of a breast mass with rapid growth. It typically appears intensely vascularized and non-calcified, predominantly hyperechoic, and hyperintense on T2-weighted MRI.
View Article and Find Full Text PDF